Meeting
2024 ASCO Genitourinary Cancers Symposium
Prostate-specific membrane antigen SPECT-CT in patients with intermediate and high-risk prostate cancer in primary diagnosis: A comparative analysis with 18F-PSMA PET/CT.
Authors
Joel E. Vargas Ahumada
Instituto Nacional de Cancerologia, Mexico City, Mexico
Joel E. Vargas Ahumada , Anna Scavuzzo , Sofia Denisse González Rueda , Pamela Casanova , Miguel Angel Jimenez-Rios , Irma Soldevilla-Gallardo , Francisco Osvaldo Garcia-Perez
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Diagnostics and Imaging
Citation
J Clin Oncol 42, 2024 (suppl 4; abstr 43)
DOI
10.1200/JCO.2024.42.4_suppl.43
Abstract #
43
Poster Bd #
A22
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
Update from the PSMA-dRT trial: A randomized phase III trial of PSMA-PET prior to definitive radiation therapy for unfavorable intermediate-risk or high-risk prostate cancer.
First Author: John Nikitas
Poster
2024 ASCO Genitourinary Cancers Symposium
Role of 18F-flotufolastat PET/CT imaging in men with high-risk prostate cancer following conventional imaging and associated changes in medical management: A phase 3b investigator-initiated trial.
First Author: Zachariah Taylor
Poster
2024 ASCO Genitourinary Cancers Symposium
Utility of PSMA PET/CT for imaging ductal carcinoma of the prostate.
First Author: Ahmed M. Mahmoud
Poster
2024 ASCO Genitourinary Cancers Symposium
SABRE: Assessment of safety and efficacy of 64Cu-SAR-BBN in patients with PSMA-negative biochemical recurrent prostate cancer.
First Author: Luke T. Nordquist